Cheyne Capital Management (UK)’s Albireo Pharma Inc ALBO Stock Holding History

Cheyne Capital Management (UK)’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,364	Closed	-$289K	–	66
2022 Q4	$289K	Buy	+13,364	New	+$282K	0.5%	50

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cheyne Capital Management (UK)'s ALBO Position: Q1 2023 in Review

Cheyne Capital Management (UK) sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 13,364 shares — an estimated $289K sold.

Cheyne Capital Management (UK) first reported a position in ALBO in Q4 2022 and held it in 1 quarter. The position peaked at $289K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Cheyne Capital Management (UK) reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Cheyne Capital Management (UK) sold 13,364 Albireo Pharma Inc shares in Q1 2023, an estimated $289K.
Cheyne Capital Management (UK) first reported a position in Albireo Pharma Inc in Q4 2022 and held it in 1 quarter.
Cheyne Capital Management (UK)'s Albireo Pharma Inc position peaked at $289K in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.